TRIALYTIX Trademark

Trademark Overview


On Friday, March 1, 2024, a trademark application was filed for TRIALYTIX with the United States Patent and Trademark Office. The USPTO has given the TRIALYTIX trademark a serial number of 98429218. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 26, 2024. The TRIALYTIX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing a web-based system and online portal featuring technology that enables users to manage clinical trial operations
trialytix

General Information


Serial Number98429218
Word MarkTRIALYTIX
Filing DateFriday, March 1, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a web-based system and online portal featuring technology that enables users to manage clinical trial operations

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Friday, March 1, 2024NEW APPLICATION ENTERED
Saturday, July 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 17, 2024ASSIGNED TO EXAMINER
Thursday, September 26, 2024NON-FINAL ACTION WRITTEN
Thursday, September 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 26, 2024NON-FINAL ACTION E-MAILED